These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 37767072)

  • 21. Prevalence and risk factors of covert hepatic encephalopathy in cirrhotic patients: A multicenter study in China.
    Zeng X; Yin C; Sun CY; Lu CH; Zhao SS; Gao XH; Chen DF; Wen LZ; Lin S; Yang P; Zhang QH; Guan YJ; Zhang Y; Ren SQ; Cai DC; Zhang J; Li L; Chang CY; Zhou XL; Shi PM; Chen SY; Lin Y; Xie WF
    J Dig Dis; 2023 Feb; 24(2):122-132. PubMed ID: 37032126
    [TBL] [Abstract][Full Text] [Related]  

  • 22. QuickStroop Predicts Time to Development of Overt Hepatic Encephalopathy and Related Hospitalizations in Patients With Cirrhosis.
    Kanagalingam G; Park D; Badal BD; Fagan A; Thacker LR; Bajaj JS
    Clin Gastroenterol Hepatol; 2024 Apr; 22(4):899-901.e2. PubMed ID: 37797903
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Validation of the Korean Stroop Test in Diagnosis of Minimal Hepatic Encephalopathy.
    Yoon EL; Jun DW; Jeong JY; Kim TY; Song DS; Ahn SB; Kim HY; Jung YK; Song MJ; Kim SE; Kim HS; Jeong SW; Kim SG; Lee TH; Cho YK; Kim JK; Ryu H
    Sci Rep; 2019 May; 9(1):8027. PubMed ID: 31142824
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Animal naming test is a simple and valid tool for detecting covert hepatic encephalopathy and predicting outcomes in Chinese-speaking regions: a preliminary study.
    Huang CH; Yu TY; Tseng WJ; Huang YT; Chang SH; Hsieh SY; Chien RN; Amodio P
    Ann Med; 2023 Dec; 55(1):2236013. PubMed ID: 37494454
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Stroop smartphone application is a short and valid method to screen for minimal hepatic encephalopathy.
    Bajaj JS; Thacker LR; Heuman DM; Fuchs M; Sterling RK; Sanyal AJ; Puri P; Siddiqui MS; Stravitz RT; Bouneva I; Luketic V; Noble N; White MB; Monteith P; Unser A; Wade JB
    Hepatology; 2013 Sep; 58(3):1122-32. PubMed ID: 23389962
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Minimal hepatic encephalopathy: a better diagnostic to improve prognostic].
    Ennaifer R; Cheikh M; Hefaiedh R; Romdhane H; Ben Nejma H; Hadj NB
    Presse Med; 2014 May; 43(5):e127-33. PubMed ID: 24703736
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Covert hepatic encephalopathy is independently associated with poor survival and increased risk of hospitalization.
    Patidar KR; Thacker LR; Wade JB; Sterling RK; Sanyal AJ; Siddiqui MS; Matherly SC; Stravitz RT; Puri P; Luketic VA; Fuchs M; White MB; Noble NA; Unser AB; Gilles H; Heuman DM; Bajaj JS
    Am J Gastroenterol; 2014 Nov; 109(11):1757-63. PubMed ID: 25178701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of Post-Traumatic Stress Disorder on Cognitive Function and Covert Hepatic Encephalopathy Diagnosis in Cirrhotic Veterans.
    Burroughs TK; Wade JB; Ellwood MS; Fagan A; Heuman DM; Fuchs M; Bajaj JS
    Dig Dis Sci; 2018 Feb; 63(2):481-485. PubMed ID: 29313245
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Minimal Hepatic Encephalopathy: The Reality Beyond Our Eyes.
    Barbosa M; Marinho C; Mota P; Cotter J
    Acta Med Port; 2015; 28(4):480-5. PubMed ID: 26574984
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cognitive reserve is a determinant of health-related quality of life in patients with cirrhosis, independent of covert hepatic encephalopathy and model for end-stage liver disease score.
    Patel AV; Wade JB; Thacker LR; Sterling RK; Siddiqui MS; Stravitz RT; Sanyal AJ; Luketic V; Puri P; Fuchs M; Matherly S; White MB; Unser A; Heuman DM; Bajaj JS
    Clin Gastroenterol Hepatol; 2015 May; 13(5):987-91. PubMed ID: 25445772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Covert hepatic encephalopathy is associated with aggressive disease progression and poor survival in patients with cirrhosis.
    Wang J; Deng MJ; Shi PM; Peng Y; Wang XH; Tan W; Wang PQ; Chen YX; Yuan ZL; Ning BF; Xie WF; Yin C
    J Dig Dis; 2023 Dec; 24(12):681-690. PubMed ID: 38108656
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stepwise diagnosis in covert hepatic encephalopathy: critical flicker frequency and MELD-score as a first-step approach.
    Greinert R; Ripoll C; Hollenbach M; Zipprich A
    Aliment Pharmacol Ther; 2016 Sep; 44(5):514-21. PubMed ID: 27385440
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Raised serum Interleukin-6 identifies patients with liver cirrhosis at high risk for overt hepatic encephalopathy.
    Labenz C; Toenges G; Huber Y; Nagel M; Marquardt JU; Schattenberg JM; Galle PR; Labenz J; Wörns MA
    Aliment Pharmacol Ther; 2019 Nov; 50(10):1112-1119. PubMed ID: 31583743
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diagnosis of covert hepatic encephalopathy without specialized tests.
    Nabi E; Thacker LR; Wade JB; Sterling RK; Stravitz RT; Fuchs M; Heuman DM; Bouneva I; Sanyal AJ; Siddiqui MS; Luketic V; White MB; Monteith P; Noble NA; Unser A; Bajaj JS
    Clin Gastroenterol Hepatol; 2014 Aug; 12(8):1384-1389.e2. PubMed ID: 24362049
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cognitive dysfunction is associated with poor socioeconomic status in patients with cirrhosis: an international multicenter study.
    Bajaj JS; Riggio O; Allampati S; Prakash R; Gioia S; Onori E; Piazza N; Noble NA; White MB; Mullen KD
    Clin Gastroenterol Hepatol; 2013 Nov; 11(11):1511-6. PubMed ID: 23707462
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Natural history of covert hepatic encephalopathy: An observational study of 366 cirrhotic patients.
    Wang AJ; Peng AP; Li BM; Gan N; Pei L; Zheng XL; Hong JB; Xiao HY; Zhong JW; Zhu X
    World J Gastroenterol; 2017 Sep; 23(34):6321-6329. PubMed ID: 28974899
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Covert hepatic encephalopathy and spontaneous portosystemic shunts increase the risk of developing overt hepatic encephalopathy.
    Greinert R; Zipprich A; Simón-Talero M; Stangl F; Ludwig C; Wienke A; Praktiknjo M; Höhne K; Trebicka J; Genescà J; Ripoll C
    Liver Int; 2020 Dec; 40(12):3093-3102. PubMed ID: 32890428
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical Predictors for Poor Quality of Life in Patients With Covert Hepatic Encephalopathy.
    Labenz C; Toenges G; Schattenberg JM; Nagel M; Sprinzl MF; Nguyen-Tat M; Zimmermann T; Huber Y; Marquardt JU; Galle PR; Wörns MA
    J Clin Gastroenterol; 2019 Aug; 53(7):e303-e307. PubMed ID: 30439761
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Minimal Hepatic Encephalopathy and Mild Cognitive Impairment Worsen Quality of Life in Elderly Patients With Cirrhosis.
    Bajaj JS; Duarte-Rojo A; Xie JJ; Acharya C; Wade JB; Robles C; Thacker LR; Flud C; Fagan A; Garcia-Saenz-de-Sicilia M; White MB; Kelly M; Nguyen V; Gavis EA; Vargas HE
    Clin Gastroenterol Hepatol; 2020 Dec; 18(13):3008-3016.e2. PubMed ID: 32205222
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proposal of Stroop test cut-off values as screening for neuropsychological impairments in cirrhosis: A Japanese multicenter study.
    Kondo Y; Iwasa M; Kawaratani H; Miyaaki H; Hanai T; Kon K; Hirano H; Shimizu M; Yoshiji H; Okita K; Koike K
    Hepatol Res; 2021 Jun; 51(6):674-681. PubMed ID: 33615662
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.